Whole body hyperthermia:: a secure procedure for patients with various malignancies?

被引:43
作者
Kerner, T [1 ]
Deja, M
Ahlers, O
Löffel, J
Hildebrandt, B
Wust, P
Gerlach, H
Riess, H
机构
[1] Humboldt Univ, Virchow Hosp, Dept Anesthesiol & Intens Care Med, Charite Med Ctr, D-13353 Berlin, Germany
[2] Humboldt Univ, Virchow Hosp, Charite Med Ctr, Dept Hematol & Oncol, D-13353 Berlin, Germany
[3] Humboldt Univ, Virchow Hosp, Charite Med Ctr, Dept Radiol, D-13353 Berlin, Germany
关键词
hyperthermia; hemodynamics; gas exchange; oncology;
D O I
10.1007/s001340050989
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To establish the safety of systemic Cancer Multistep Therapy (sCMT) including whole body hyperthermia, by means of hemodynamic, laboratory and clinical investigations. Design: Prospective study. Setting: University clinic. Patients: 12 patients with various cancers (with sCMT), a second group of 20 patients with colorectal carcinoma treated with chemotherapy (without sCMT). Interventions: 25 treatments with sCMT for 60 min at 41.8 degrees C (including chemotherapy) were given in addition to induced hyperoxemia and hyperglycemia under general anesthesia. Measurements and results: Invasive monitoring of systemic and pulmonary hemodynamics as well as pulmonary gas exchange was used at 37 degrees C, 40 degrees C, 41.8 degrees C and 39 degrees C. In addition, laboratory parameters were measured before and within 4 days of therapy. At 41.8 degrees C, invasive monitoring showed characteristic signs of hyperdynamic circulation. In addition, right-to-left shunt, oxygen consumption, oxygen delivery and lactate levels were significantly different from pretreatment values. At the end of therapy, lactate levels and the extravascular lung water index increased, whereas all other parameters showed a clear tendency to return to initial values. Within the first day after sCMT, we measured a slight but significant reversible increase in serum creatinine compared to pretreatment values, but found no significant alterations of other chemical parameters. Between the sCMT group and controls, there was only a temporary significant difference in aspartate aminotransferase levels 2 days after therapy. Conclusions: sCMT, including whole body hyperthermia, accompanied by suitable anesthesiological management and monitoring, does not lead to any serious or sustained organ dysfunction and can therefore be regarded as a safe therapy.
引用
收藏
页码:959 / 965
页数:7
相关论文
共 24 条
[1]  
BARLOGIE B, 1979, CANCER RES, V39, P1481
[2]   ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA [J].
BARRY, MA ;
BEHNKE, CA ;
EASTMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2353-2362
[3]   The use of esmolol in whole-body hyperthermia: Cardiovascular effects [J].
Berry, JM ;
Michalsen, A ;
Nagle, V ;
Bull, JMC .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1997, 13 (03) :261-268
[4]   Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity [J].
Brauer, LP ;
Prieshof, B ;
Wiedemann, GJ ;
Weiss, C ;
Kriz, W ;
Schramm, U ;
Robins, HI ;
Pagel, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (10) :549-554
[5]   CHEMOTHERAPY RESISTANT SARCOMA TREATED WITH WHOLE-BODY HYPERTHERMIA (WBH) COMBINED WITH 1-3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU) [J].
BULL, JMC ;
CRONAU, LH ;
NEWMAN, BM ;
JABBOURY, K ;
ALLEN, SJ ;
OHNO, S ;
SMITH, T ;
TONNESEN, AS .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1992, 8 (03) :297-304
[6]   CARDIOVASCULAR CHANGES DURING WHOLE-BODY HYPERTHERMIA TREATMENT OF ADVANCED MALIGNANCY [J].
FAITHFULL, NS ;
REINHOLD, HS ;
VANDENBERG, AP ;
VANRHOON, GC ;
VANDERZEE, J ;
WIKEHOOLEY, JL .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1984, 53 (03) :274-281
[7]  
Foxall PJD, 1997, CLIN CANCER RES, V3, P1507
[8]   HEMODYNAMIC AND PLASMA-CATECHOLAMINE RESPONSES TO HYPERTHERMIC CANCER-THERAPY IN HUMANS [J].
KIM, YD ;
LAKE, CR ;
LEES, DE ;
SCHUETTE, WH ;
BULL, JM ;
WEISE, V ;
KOPIN, IJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 237 (05) :H570-H574
[9]   ANESTHETIC MANAGEMENT OF WHOLE-BODY HYPERTHERMIA FOR THE TREATMENT OF CANCER [J].
LEES, DE ;
KIM, YD ;
BULL, JM ;
WHANGPENG, J ;
SCHUETTE, W ;
SMITH, R ;
MACNAMARA, TE .
ANESTHESIOLOGY, 1980, 52 (05) :418-428
[10]  
OSTROW S, 1981, CANCER TREAT REP, V65, P323